Evidence map›Paper›PMID 41215807›Full record

ArticleSchizophrenia research. Cognition2026

Self-reported cognitive functioning on the behavior rating inventory of executive function in psychotic disorders: Effects of gender, education and cognitive functioning.

Eivind Haga Ronold, Rune Raudeberg

Abstract read
In one paragraph

Article in Schizophrenia research. Cognition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eivind Haga RonoldDepartment of Biological and Medical Psychology, University of Bergen, Postboks 7807 NO, 5020, Bergen, Norway.
Rune RaudebergDepartment of Biological and Medical Psychology, University of Bergen, Postboks 7807 NO, 5020, Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Psychotic disorders (PD) are among the most severe mental disorders and cognitive impairment contributes to this. Few studies have investigated self-reported executive function (srEF)in PD using the Behavior Rating Inventory of Executive Function Adult version (BRIEF-A) and have found varying results. Population characteristics could contribute to this heterogeneity. The current study thus reported BRIEF-A scores in a sample with PD, and how this was affected by gender, education and cognitive function measured by The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Methods: BRIEF-A consist of 9 scales, two indices (Behavioral Regulation Index [BRI] and Metacognition Index [MI]), ands a summary score Global Executive Composite (GEC). T-scores (high score = difficulties) from 260 patients (99 women, mean age 24.58) was included. Independent samples t-tests were used to compare means between genders. Gender, RBANS Total Scale scores and years of education were used to predict BRIEF-A scores in general linear mixed models. Results: For the full sample, the BRIEF-A the GEC showed a marginally impaired T-score (T >60) and the MI showed highest scores. Females had a GEC and MI score above clinical cutoff (T ≥65), and had significantly more srEF difficulties on all scales except Inhibit and Self-Monitor. Gender and global cognition showed some multivariate interactions, but these effects were small. Conclusions: The current study indicates srEF marginally impaired meta-cognition in PD, enhanced by gender. Future studies should investigate srEF longitudinally to see how this develops following psychosis onset and identify groups in need of targeted treatments like cognitive remediation.

Identifiers

PMID41215807
PMCPMC12597073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.